Slow-release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohn's disease.

A double-blind, placebo-controlled trial of a slow-release preparation of 5-amino-salicylic acid (Pentasa) has been performed in 40 patients with active Crohn's disease. Over a 6-week period, Pentasa (1.5 g daily) was no different to the dummy tablet in terms of clinical activity (Harvey-Bradsh...

全面介绍

书目详细资料
Main Authors: Mahida, Y, Jewell, D
格式: Journal article
语言:English
出版: 1990
_version_ 1826342812291956736
author Mahida, Y
Jewell, D
author_facet Mahida, Y
Jewell, D
author_sort Mahida, Y
collection OXFORD
description A double-blind, placebo-controlled trial of a slow-release preparation of 5-amino-salicylic acid (Pentasa) has been performed in 40 patients with active Crohn's disease. Over a 6-week period, Pentasa (1.5 g daily) was no different to the dummy tablet in terms of clinical activity (Harvey-Bradshaw Index) or laboratory indicators of inflammation. No serious adverse reactions occurred.
first_indexed 2024-03-06T23:11:01Z
format Journal article
id oxford-uuid:6578cf57-18d5-45ea-b863-a2892efb51f8
institution University of Oxford
language English
last_indexed 2024-03-06T23:11:01Z
publishDate 1990
record_format dspace
spelling oxford-uuid:6578cf57-18d5-45ea-b863-a2892efb51f82022-03-26T18:25:40ZSlow-release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohn's disease.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6578cf57-18d5-45ea-b863-a2892efb51f8EnglishSymplectic Elements at Oxford1990Mahida, YJewell, DA double-blind, placebo-controlled trial of a slow-release preparation of 5-amino-salicylic acid (Pentasa) has been performed in 40 patients with active Crohn's disease. Over a 6-week period, Pentasa (1.5 g daily) was no different to the dummy tablet in terms of clinical activity (Harvey-Bradshaw Index) or laboratory indicators of inflammation. No serious adverse reactions occurred.
spellingShingle Mahida, Y
Jewell, D
Slow-release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohn's disease.
title Slow-release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohn's disease.
title_full Slow-release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohn's disease.
title_fullStr Slow-release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohn's disease.
title_full_unstemmed Slow-release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohn's disease.
title_short Slow-release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohn's disease.
title_sort slow release 5 amino salicylic acid pentasa for the treatment of active crohn s disease
work_keys_str_mv AT mahiday slowrelease5aminosalicylicacidpentasaforthetreatmentofactivecrohnsdisease
AT jewelld slowrelease5aminosalicylicacidpentasaforthetreatmentofactivecrohnsdisease